Lenalidomide as induction therapy before allogeneic stem cell transplantation in a patient with proliferative CMML-2 and del(5q) not involving the EGR1 locus.

Source:http://linkedlifedata.com/resource/pubmed/id/17581611

Download in:

View as

General Info

PMID
17581611